Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Science News
Resources
Drug development
Poster
Tailored by Design: Rethinking the Path to Biosimilar Development
Analytics
,
Bioanalytics
,
Biosimilars
,
Drug development
,
EMA
,
Mabion
Scaling up Biologics Production at Mabion with Single-use Bioreactors and Automated Monitoring
Biologics
,
Drug development
,
GMP
,
Mabion
,
Manufacturing
Oncologic Bispecific Antibodies in Immunotherapy
Biologics
,
Bispecific antibody
,
Cancer
,
Drug development
Bioprocess Optimization Across Upstream and Downstream Processing
Drug development
,
Drug product
,
Drug substance
,
Manufacturing
Tailoring Cell Line Development for Efficient Biologics Process Outcomes
Biologics
,
Drug development
,
GMP
,
Manufacturing
Challenges and Solutions in ADC Development for Biologic Therapeutics
Antibody-drug conjugates
,
Biologics
,
Drug development
GMP Biologics Manufacturing in End-to-End Drug Development
Biologics
,
Drug development
,
GMP
,
Manufacturing
5 Analytical Challenges in Biosimilar Characterization and Comparability
Biologics
,
Drug development
Poster
Integrated Modeling of Upstream and Downstream Bioprocessing to Improve Biologics Production Efficiency
Biologics
,
Drug development
,
Mabion
,
Manufacturing
1
2
3
Next